Biotech Beast (@Biotech_Beast) profile picture

Pharmacologist and biotech trader. Focus on trading around biotech catalysts. Tweets are not investment advice. May have a position in names I tweet about.

Joined November 2017
3500 people have died from long covid according to the CDC Level of evidence: misinformation vinayprasadmdmph.substack.co…
22
64
3
344
21,469
$NLSP Data is off the charts!
1
2
$NLSP (+9.6% pre) NLS Pharmaceutics (NLSP) Announces Positive Top-Line Results from Phase 2a Clinical Trial of Once-Daily Quilience for Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcoleps - SI ooc.bz/l/108621
$NLSP NLS Pharmaceutics Announces Positive Top-Line Results from its Phase 2a Clinical Trial of Once-Daily Quilience(R) ... accesswire.com/717598/NLS-Ph…
1
1
Popular thread. Here is the video version. Explains the core themes & more youtu.be/Ft2hupW0aak
It Is Now Undeniable 👇 Vaccine can cause more Myocarditis in Men Under 40 Than COVID-19; Just OUT! Patrone Circ 2022; I have said repeatedly Moderna should be banned in Men<40 FDA failed Americans & this analysis is more complicated Everyone gets breakthrough eventually 1/7
5
72
4
235
Social Media Is Lying to You About Antidepressants by @jodyserrano featuring myself, @drjessigold, @tylerblack32 lifehacker.com/social-media-…
16
48
7
156
Biotech stocks are +31% $XBI/+17% $IBB since 6/13 but still -28%/-19% ytd. What is the major reason/driver? Read our views: https://nitter.gq/t.co/Fnc78CFbwy $BBH $NBI $PBE $SAVA $BIIB $NVAX $DNA $BMY $GSK $ABBV $MRNA $MRK $AZN $JNJ $GILD $ASND $BLUE $AMGN $ICPT $CRSP $ACAD $REGN $VRTX
42%Biotech M&A activity
33%Current vs histor prices
9%Political/drug pricing
16%Other (please comment)
45 votes • Final results
3
1
Biotech Beast retweeted
Another winner $XAIR on FDA approval news. Stock up 23% after hours Needs to clear 8 for higher price action
$XAIR this stock could have a good spike on any FDA news in regards to labelling discussion and or approval like $AXSM Hopefully news soon on $XAIR. Holding shares.
4
2
37
Biotech Beast retweeted
"Home prices are up 30% broadly in the United States for the past two years and mortgage rates on the 30-year fixed mortgage have doubled," Gundlach continued. "What that means is that the monthly payment for the same house from two years ago is now double."
Biotech Beast retweeted
In hindsight, this moment was the top $UPST
219
908
311
6,479
Replying to @VPrasadMDMPH
A factorial trial of masking on planes could’ve been run so rapidly and so cheaply In fact so many **large simple** public health trials could’ve been run so quickly History will judge us poorly that zero were conducted. At every step we chose to be ignorant
82
72
5
725
A case (among several) for $sava share price target $0 in three slides:
4
1
25
Biotech Beast retweeted
$SAVA To be perfectly clear, FDA only denied the citizen petition on procedural grounds CDER Director makes it clear that it "doesn't represent a decision by the Agency to take or refrain from taking any action", e.g. potential clinical hold if IND found based on fabricated data
10
14
4
66
Biotech Beast retweeted
Exciting 2022 coming up for $PDSB with 7 trials in clinic. PDS0101 -Versatile 002 (keytruda combo)-data Q1. Enrolment completed Oct 4th, 2 scans to confirm at least 30% ORR @ 9/18 weeks puts us around mid Feb for PR to see if they hit their 4/17 target. Ckpt ref. 2/21 -2nd half
2
4
3
47
Have to hand it to the EMA. They spell out rejections. So aducanumab was soundly rejected due to conflicting data, no clear link between amyloid and Alzheimer's and concerns it's dangerous. All the things that would lead a rational FDA to the same conclusion. #regulatorycapture
8
34
4
202
For all those wanting to catch up on the $SAVA story (there are several chapters as of now), this is an interesting read: forbetterscience.com/2021/12…
1
1
2
9
1 of 6: #Omicron - Is this the end of the pandemic? No restrictions will be needed to protect hospitals in any way in any country. Gauteng, South Africa has peaked with case levels similar to Delta, but with deaths expected to be 25 times lower.
339
3,152
1,207
8,017